CRISPR Therapeutics AG (NASDAQ:CRSP), ended its previous trading session at $39.44 showing a gain of 0.769999999999996 or 1.99 percent with respect to the price of $38.67 when stock market opened. The company traded 455390 shares over the course of the trading day. Giving the average volume of 702.15 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 52.13 Million.
CRISPR Therapeutics AG (NASDAQ:CRSP) is currently trading lower than its price target which is set to $56.83 by the analyst. The stock is -46.63% Below its 1-Year High which is $73.90. CRSP has a difference of 77.5% from its 1 year low which stands at $22.22. The company is currently rated by analyst who are keeping a close eye on the stock as 2.5. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
CRISPR Therapeutics AG (NASDAQ:CRSP) Performance Snapshot
The stock performed exceptionally bad in the previous week which depicts an decrease of -1.38 percent in the shares price. The company added about 0.92% in its share price over 1-Month. While taking about the performance of the stock over 1-year interval is -31.71 Percent. CRSP currently shows 38.05% as its year to date performance.
CRISPR Therapeutics AG (NASDAQ:CRSP) Price Insight
The stock needs to grow about $17.39 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 0.66%, 3.35% and 2.22 percent respectively. The stock trades about 17.47 percent of its Float giving its total shares Outstanding are 52.13 Million. CRSP gained about 9.04 percent in 6 months showing its Average True Range of 2.11. The company currently has a RSI and Beta of 51.85 and 0.
While talking about CRISPR Therapeutics AG (NASDAQ:CRSP) valuation ratios, the stock trades with a P/S and P/B of 979.05 and 5.41 which is significantly better and attractive as compared to its peers.